Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Iczkowski

Showing results (31-40 of 182) with videos related to

Pageof 19
Sort By:
The Journal of Urology|September 8, 2020
Eight Endorsements of the International Society of Urological Pathology from the 2019 Consensus Conference on Grading of Prostatic CarcinomaKenneth A Iczkowski, Geert J L H van Leenders
Molecular Biotechnology|October 13, 2004
Metafectene is superior to lipofectamine in the transfection of G(s) alpha prostate cancer cellsKenneth A Iczkowski, A Levi Omara-Opyene, Roland Klösel
Cancers|August 10, 2024
Predicting the Diagnosis of Prostate Cancer with a Novel Blood-Based Biomarker: Comparison of Its Performance with Prostate-Specific AntigenJohnmesha L Sanders, Kenneth A Iczkowski, Girish V Shah
Medical Hypotheses|July 18, 2006
Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosisJoseph M Alisky, Elena L Chertkova, Kenneth A Iczkowski
BMC Cancer|July 8, 2005
Further evidence for increased macrophage migration inhibitory factor expression in prostate cancerKatherine L Meyer-Siegler, Kenneth A Iczkowski, Pedro L Vera
Advances in Anatomic Pathology|August 19, 2017
The New Realization About Cribriform Prostate CancerKenneth A Iczkowski, Gladell P Paner, Theodorus Van der Kwast
Medicinal Research Reviews|August 14, 2012
Metastasis suppressors in human benign prostate, intraepithelial neoplasia, and invasive cancer: their prospects as therapeutic agentsZahraa I Khamis, Kenneth A Iczkowski, Qing-Xiang Amy Sang
The Prostate|March 15, 2026
Exosomal ZFPL1 Identifies Neuroendocrine and Stem Cell-Like Prostate Cancer Subtypes?Neshat Masud, Johnmesha Sanders, Kenneth A Iczkowski, et al.
Anticancer Research|August 5, 2006
The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expressionKenneth A Iczkowski, A Levi Omara-Opyene, Girish V Shah
Analytical Biochemistry|July 10, 2007
Anion exchange fractionation of serum proteins versus albumin eliminationZiad J Sahab, Kenneth A Iczkowski, Qing-Xiang Amy Sang
Pageof 19

Showing results (31-40 of 182) with videos related to

Sort By:
Pageof 19
The Journal of Urology|September 8, 2020
Eight Endorsements of the International Society of Urological Pathology from the 2019 Consensus Conference on Grading of Prostatic CarcinomaKenneth A Iczkowski, Geert J L H van Leenders
Molecular Biotechnology|October 13, 2004
Metafectene is superior to lipofectamine in the transfection of G(s) alpha prostate cancer cellsKenneth A Iczkowski, A Levi Omara-Opyene, Roland Klösel
Cancers|August 10, 2024
Predicting the Diagnosis of Prostate Cancer with a Novel Blood-Based Biomarker: Comparison of Its Performance with Prostate-Specific AntigenJohnmesha L Sanders, Kenneth A Iczkowski, Girish V Shah
Medical Hypotheses|July 18, 2006
Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosisJoseph M Alisky, Elena L Chertkova, Kenneth A Iczkowski
BMC Cancer|July 8, 2005
Further evidence for increased macrophage migration inhibitory factor expression in prostate cancerKatherine L Meyer-Siegler, Kenneth A Iczkowski, Pedro L Vera
Advances in Anatomic Pathology|August 19, 2017
The New Realization About Cribriform Prostate CancerKenneth A Iczkowski, Gladell P Paner, Theodorus Van der Kwast
Medicinal Research Reviews|August 14, 2012
Metastasis suppressors in human benign prostate, intraepithelial neoplasia, and invasive cancer: their prospects as therapeutic agentsZahraa I Khamis, Kenneth A Iczkowski, Qing-Xiang Amy Sang
The Prostate|March 15, 2026
Exosomal ZFPL1 Identifies Neuroendocrine and Stem Cell-Like Prostate Cancer Subtypes?Neshat Masud, Johnmesha Sanders, Kenneth A Iczkowski, et al.
Anticancer Research|August 5, 2006
The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expressionKenneth A Iczkowski, A Levi Omara-Opyene, Girish V Shah
Analytical Biochemistry|July 10, 2007
Anion exchange fractionation of serum proteins versus albumin eliminationZiad J Sahab, Kenneth A Iczkowski, Qing-Xiang Amy Sang
Pageof 19